The purpose of this study is to evaluate the effectiveness and safety of a new biopsy track ablation device for liver biopsy.
Background: * Percutaneous biopsy for hepatic masses has a potential risk of bleeding and peritoneal tumor seeding. * A new device for biopsy track ablation has been invented to reduce the risk of bleeding and peritoneal tumor seeding. Method: * Routine percutaneous biopsy for hepatic masses is performed. * Immediate after obtaining tissue, biopsy needle track is ablated with a new biopsy tract ablator. * Immediate (with ultrasound) and 24 hours (with CT scan) after procedure, occurrence of complications is evaluated.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
After percutaneous ultrasound guided biopsy for hepatic masses is performed, biopsy track is ablated with a new track ablation device.
Number of participants with complications
If procedure-related complications are suspected clinically, appropriate tests such as CT scan or Ultrasound are performed and complications are evaluated. If procedure-related complications are not suspected, non-contrast CT scan is performed at 24 hours after procedure and complications are evaluated.
Time frame: within 24 hours after procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.